news
Research focus should remain on high quality studies during COVID-19 pandemic, say scientists
Exceptions to high quality research should not be made simply because of the COVID-19 pandemic, argue scientists in a new commentary.
List view / Grid view
Industry Insight
article
Post-Brexit: impact in the Life Sciences sector (so far)
In a Q&A with European Pharmaceutical Review, Marie Manley, Partner at Sidley Austin and Will Holmes, Associate at Sidley Austin discuss the post-Brexit landscape for Life Sciences.
news
FDA approves IMBRUVICA® (ibrutinib) for treatment of chronic lymphocytic leukaemia and small lymphocytic lymphoma
IMBRUVICA (ibrutinib), in combination with rituximab, has been given approval in the US for the treatment of chronic lymphocytic leukaemia and small lymphocytic lymphoma.
news
CDMO recognised in six outsourcing award categories
A Contract Development and Manufacturing Organisation (CDMO) has been recognised in six different categories at the 2020 CMO Leadership Awards.
news
COVID-19 pandemic spurs cyber-attacks on healthcare sector, says report
According to new research, as the healthcare and pharma sector relies on IT throughout the COVID-19 pandemic, cyber-attacks will be inevitable.
news
NICE recommends Vitrakvi (larotrectinib) for use on Cancer Drugs Fund
Larotrectinib has been given a positive opinion by NICE, following the submission of a revised price after it was previously rejected.
news
UK national priority COVID-19 trial now recruiting patients
The PRINCIPLE trial aims to evaluate therapeutics that could slow the progression of COVID-19 symptoms in patients most at risk of complications.
news
Sir Andrew Whitty to co-lead WHO COVID-19 vaccine effort
Whitty will take a leave of absence, effective today, to co-lead a global effort by the World Health Organization (WHO) to accelerate the development of a COVID-19 vaccine.
news
Novo Nordisk offers free 90-day insulin supply to patients due to COVID-19
Novo Nordisk has set up a programme to allow patients in the US experiencing financial hardship because of COVID-19 to receive free insulin for 90 days.
news
Open letter calls for UK government to stop pharma profiting from COVID-19
An open letter from aid organisations and academics has called on the UK government to stipulate conditions for pharmaceutical companies using public funding for COVID-19 vaccines.
article
Cutting the financial and time costs of regulatory affairs with automation
An exploration of how automation tools and AI could revolutionise the regulatory affairs sector with Ronan Brown, Senior Vice President and Head of Integrated Global Compliance at IQVIA.
news
FDA grants emergency use authorisation to blood purification system for COVID-19
A blood purification system to reduce cytokine storms in COVID-19 patients has been given emergency use authorisation by the FDA.
article
Productivity in pharma could be drastically improved with IoT implementation
Phoebe Chubb explores research that suggests laboratory productivity could be improved by 30 to 40 percent with digitalisation and IoT implementation.
news
EMA task force established to co-ordinate rapid regulatory action for COVID-19 medicines
The COVID-19 EMA pandemic Task Force (COVID-ETF) will aid in the development, authorisation and safety monitoring of COVID-19 vaccines and therapeutics.
article
COVID-19 and big pharma: what are 15 leading companies doing to develop a coronavirus vaccine?
A new report has revealed the vaccine R&D efforts of 15 of the leading pharmaceutical companies to combat the COVID-19 coronavirus.
